Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers

Carcinogenesis

Volumn 33, Issue 4, 2012, Pages 804-809

  Yuan, Jian Min ^a,b   Gao, Yu Tang ^c   Wang, Renwei ^a   Chen, Menglan ^d   Carmella, Steven G ^d   Hecht, Stephen S ^d  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACETYLCYSTEINE; ACROLEIN; BENZENE; COTININE; CROTONALDEHYDE; ETHYLENE OXIDE; NICOTINIC ACID; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; URINALYSIS;

EID: 84859646950     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs026     Document Type: Article

References (50)

1. Ferlay, J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Siegel, R. et al. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin., 61, 212-236.
3. Jemal, A. et al. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
4. International Agency for Research on Cancer. (2004) Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 83, IARC Scientific Publications, Lyon, pp. 36-40.
5. Thun, M. J. et al. (2002) Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene, 21, 7307-7325.
6. Peto, R. et al. (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ, 321, 323-329.
7. International Agency for Research on Cancer. (2007) Smokeless tobacco and tobacco-specific nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Scientific Publications, Lyon.
8. Yuan, J. M. et al. (2009) Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res., 69, 2990-2995.
9. Church, T. R. et al. (2009) A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol. Biomarkers Prev., 18, 260-266.
10. Yuan, J. M. et al. (2011) Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res., 71, 6749-6757.
11. Carmella, S. G. et al. (2009) Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem. Res. Toxicol., 22, 734-741.
12. Hecht, S. S. (2012) Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine Tob. Res., 14, 18-28.
13. Huff, J. E. et al. (1985) Multiple organ carcinogenicity of 1, 3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science, 227, 548-549.
14. International Agency for Research on Cancer (2008) 1, 3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 97, IARC Scientific Publications, Lyon, pp. 45-309.
15. Farris, G. M. et al. (1993) Carcinogenicity of inhaled benzene in CBA mice. Fundam. Appl. Toxicol., 20, 503-507.
16. U. S. Department of Health and Human Services (2004) Report on Carcinogens. National Institute of Environmental Health Sciences, U. S. Government. Research Triangle Park, NC, pp. III-37-III-39.
17. Yin, S. N. et al. (1989) A retrospective cohort study of leukemia and other cancers in benzene workers. Environ. Health Perspect., 82, 207-213.
18. Hayes, R. B. et al. (1996) Mortality among benzene-exposed workers in China. Environ. Health Perspect., 104 (suppl. 6), 1349-1352.
19. Sorahan, T. et al. (2005) Cancer risks in a historical UK cohort of benzene exposed workers. Occup. Environ. Med., 62, 231-236.
20. International Agency for Research on Cancer (1987) Overall evaluation of carcinogenicity: an updating of IARC Monographs Volumes 1-42. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. IARC Scientific Publications, Lyon.
21. Hecht, S. S. et al. (2010) Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem. Res. Toxicol., 23, 1001-1008.
22. International Agency for Research on Cancer (1995) Acrolein. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 63, IARC Scientific Publications, Lyon, pp. 337-372.
23. Zhang, S. et al. (2007) Detection and quantitation of acrolein-derived 1, N2-propanodeoxyguanosine adducts in human lung by liquid chromatographyelectrospray ionization-tandem mass spectrometry. Chem. Res. Toxicol., 20, 565-571.
24. Feng, Z. et al. (2006) Acrolein is a major cigarette-related lung cancer agent: preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl Acad. Sci. USA, 103, 15404-15409.
25. Thompson, C. A. et al. (2008) Genome-wide transcriptional responses to acrolein. Chem. Res. Toxicol., 21, 2245-2256.
26. Chung, F. L. et al. (1999) Role of 1, N2-propanodeoxyguanosine adducts as endogenous DNA lesions in rodents and humans. In Singer, B. and Bartsch, H. (eds) Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis. IARC Scientific Publications, Lyon, pp. 45-54.
27. Ross, R. K. et al. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
28. Yuan, J. M. et al. (1996) Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA, 275, 1646-1650.
29. Yuan, J. M. et al. (2011) Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res., 71, 6749-6757.
30. Winer, B. J. (1971) Statistical Principles in Experimental Design. McGraw-Hill, New York.
31. Breslow, N. E. et al. (1980) Statistical methods in cancer research. The Analysis of Case-Control Studies, Vol. 1, IARC Scientific Publication, Lyon.
32. Thyssen, J. et al. (1981) Inhalation studies with benzo[a]pyrene in Syrian golden hamsters. J. Natl Cancer Inst., 66, 575-577.
33. International Agency for Research on Cancer (2010) Some nonheterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 92, IARC Scientific Publications, Lyon, pp. 35-818.
34. Hecht, S. S. (1998) Biochemistry, biology, and carcinogenicity of tobaccospecific N-nitrosamines. Chem. Res. Toxicol., 11, 559-603.
35. Belinsky, S. A. et al. (1990) Dose-response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res., 50, 3772-3780.
36. Rivenson, A. et al. (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res., 48, 6912-6917.
37. National Toxicology Program. (1986) NTP toxicology and carcinogenesis studies of benzene (CAS No. 71-43-2) in F344/N rats and B6C3F1 mice (Gavage studies). Natl Toxicol. Program Tech. Rep. Ser., 289, 1-277.
38. Chung, F. L. et al. (1986) Induction of liver tumors in F344 rats by crotonaldehyde. Cancer Res., 46, 1285-1289.
39. Hecht, S. S. et al. (2010) Analysis of phenanthrene and benzo[a]pyrene tetraol enantiomers in human urine: relevance to the bay region diol epoxide hypothesis of benzo[a]pyrene carcinogenesis and to biomarker studies. Chem. Res. Toxicol., 23, 900-908.
40. Hukkanen, J. et al. (2005) Metabolism and disposition kinetics of nicotine. Pharmacol. Rev., 57, 79-115.
41. Henderson, A. P. et al. (2005) Reactions of benzene oxide with thiols including glutathione. Chem. Res. Toxicol., 18, 265-270.
42. Hecht, S. S. et al. (2003) r-1, t-2, 3, c-4-Tetrahydroxy-1, 2, 3, 4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. Cancer Epidemiol. Biomarkers Prev., 12, 1501-1508.
43. Divine, B. J. et al. (2001) A cohort mortality study among workers at a 1, 3 butadiene facility. Chem. Biol. Interact., 135-136, 535-553.
44. Tsai, S. P. et al. (2001) A mortality, morbidity, and hematology study of petrochemical employees potentially exposed to 1, 3-butadiene monomer. Chem. Biol. Interact., 135-136, 555-567.
45. Alder, N. et al. (2006) Meta-analysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry. Am. J. Epidemiol., 164, 405-420.
46. Sathiakumar, N. et al. (2009) 1, 3-Butadiene, styrene and lung cancer among synthetic rubber industry workers. J. Occup. Environ. Med., 51, 1326-1332.
47. Teta, M. J. et al. (1999) Ethylene oxide cancer risk assessment based on epidemiological data: application of revised regulatory guidelines. Risk Anal., 19, 1135-1155.
48. Curado, M. P. et al. (2007) Cancer Incidence in Five Continents. IARC Scientific Publications No. 160, Lyon.
49. Church, T. R. et al. (2010) Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers. Biomarkers, 15, 345-352.
50. Hecht, S. S. et al. (2005) Longitudinal study of urinary phenanthrene metabolite ratios: effect of smoking on the diol epoxide pathway. Cancer Epidemiol. Biomarkers Prev., 14, 2969-2974.